StoxGud Sign in
10

Deccan Cements Limited

NSE: DECCANCE · Unclassified

₹479.20+0.40%06 Nov 2026

Ask the data

Instant answers about Deccan Cements Limited — computed from its filings, no language model
Market cap₹671 cr
Current price₹479.20
High / Low₹1,044 / ₹467
P/E114.9
P/B0.89
Book value₹535.9
ROE0.8%
ROCE2.9%
Debt / equity1.00
Dividend yield0.13%
EPS (TTM)₹4.17
Face value₹5

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin
FY25FY26
Revenue527.0635.6
EBITDA35.476.6
Operating margin6.7%12.1%
Interest12.827.3
Depreciation28.135.6
Profit before tax10.734.2
Tax3.25.7
Net profit7.528.6
EPS ₹5.3720.40
Operating cash flow-37.675.6
Capex243.1171.6
Dividend paid4.20.8
Total assets1,625.41,710.9
Equity722.4750.7

Quarterly performance

last 9 quarters · ₹ crore
showing latest 8 of 9 periods
JUN '24SEP '24DEC '24MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26
Revenue172.2120.5115.5118.9150.6140.3130.8213.9219.3
Operating profit11.32.28.713.127.920.111.417.216.9
Operating margin6.6%1.8%7.6%11.0%18.5%14.4%8.7%8.1%7.7%
Other income3.02.93.37.02.72.31.61.07.1
Interest3.03.43.52.83.53.35.515.015.7
Depreciation7.07.17.16.96.76.78.214.015.5
Profit before tax4.3-5.51.510.420.512.5-0.72.0-9.5
Tax1.5-1.40.72.55.13.4-0.1-2.7-2.1
Net profit2.8-4.00.88.015.39.1-0.64.7-7.4
EPS ₹2.00-2.890.585.6810.966.47-0.403.37-5.24
Revenue YoY————-12.5%16.5%13.3%79.9%45.7%
Profit YoY————446.3%—-169.1%-40.6%-148.1%

Earlier results (standalone, Sep '07 – Mar '24)

₹ crore · from BSE, before the NSE XBRL filings begin

Deccan Cements Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 15 periods
FY09†FY10†FY11†FY13†FY14†FY15†FY16†FY17†FY18†FY19†FY20†FY21†FY22†FY23†FY24†
Revenue202.7296.5338.5499.1390.8438.6579.1625.9594.1651.4555.9758.6791.8781.5799.4
Operating profit65.474.064.364.956.865.4114.699.485.095.278.3175.9161.397.293.8
Operating margin32.2%25.0%19.0%13.0%14.5%14.9%19.8%15.9%14.3%14.6%14.1%23.2%20.4%12.4%11.7%
Other income1.52.84.83.02.62.01.52.04.39.99.610.110.79.316.0
Interest4.634.039.530.727.426.615.26.75.87.76.87.410.212.512.4
Depreciation7.023.824.124.624.419.520.321.522.722.320.923.225.927.427.6
Profit before tax55.318.95.412.67.721.380.673.260.975.050.5155.4117.366.653.5
Tax21.114.63.45.32.61.535.026.722.329.0-6.140.229.717.316.2
Net profit34.24.32.07.35.019.945.646.638.546.156.6115.187.649.337.3

Quarters

showing latest 8 of 66 periods
SEP '07†DEC '07†MAR '08†JUN '08†SEP '08†DEC '08†MAR '09†JUN '09†SEP '09†DEC '09†MAR '10†JUN '10†SEP '10†DEC '10†MAR '11†JUN '11†SEP '11†DEC '11†JUN '12†SEP '12†DEC '12†MAR '13†JUN '13†SEP '13†DEC '13†MAR '14†JUN '14†SEP '14†DEC '14†MAR '15†JUN '15†SEP '15†DEC '15†MAR '16†JUN '16†SEP '16†DEC '16†MAR '17†JUN '17†SEP '17†DEC '17†MAR '18†JUN '18†SEP '18†DEC '18†MAR '19†JUN '19†SEP '19†DEC '19†MAR '20†JUN '20†SEP '20†DEC '20†MAR '21†JUN '21†SEP '21†DEC '21†MAR '22†JUN '22†SEP '22†DEC '22†MAR '23†JUN '23†SEP '23†DEC '23†MAR '24†
Revenue58.249.353.358.739.353.850.986.282.259.868.379.270.784.3104.2134.3123.5115.8138.0134.2115.6111.3100.3100.8101.088.779.0109.8102.2147.6158.8153.4125.8141.1132.0167.5152.4174.1160.3136.2134.0163.7161.7162.5173.1154.1182.1134.2115.8123.8138.6198.1208.1213.8224.2190.9190.5186.2194.0180.5211.1195.9192.1167.2216.9223.2
Operating profit23.818.417.519.812.215.917.529.124.84.815.411.13.619.030.629.527.123.822.316.914.111.69.811.616.319.15.516.514.129.328.434.621.330.323.527.223.325.424.621.018.121.423.021.322.928.140.416.010.611.339.950.048.937.055.438.743.224.134.816.825.120.525.213.728.626.3
Operating margin41.0%37.4%32.9%33.7%31.0%29.5%34.5%33.7%30.1%7.9%22.5%14.0%5.1%22.5%29.4%22.0%22.0%20.5%16.2%12.6%12.2%10.4%9.8%11.5%16.2%21.6%6.9%15.0%13.8%19.9%17.9%22.6%16.9%21.5%17.8%16.2%15.3%14.6%15.3%15.4%13.5%13.1%14.2%13.1%13.2%18.2%22.2%11.9%9.1%9.1%28.8%25.2%23.5%17.3%24.7%20.3%22.7%12.9%17.9%9.3%11.9%10.5%13.1%8.2%13.2%11.8%
Other income0.90.31.20.50.50.30.30.20.91.00.50.30.30.23.90.50.41.50.20.80.81.20.30.50.31.40.90.50.50.20.30.20.10.80.80.30.20.70.50.92.20.61.71.92.04.32.03.72.01.92.12.32.43.22.61.92.63.62.71.71.73.13.13.74.34.9
Interest0.10.10.20.20.30.73.46.77.77.312.49.79.710.210.010.210.710.28.88.37.66.06.86.76.97.06.86.86.46.65.23.93.13.01.71.61.42.01.41.51.51.41.61.61.62.91.41.91.91.61.41.41.33.32.22.52.82.73.02.73.33.52.42.93.83.3
Depreciation1.41.51.51.41.51.52.64.44.75.09.76.16.16.05.96.16.26.06.16.26.26.16.16.16.16.03.72.94.48.45.15.25.24.95.25.35.25.75.65.75.75.75.25.75.65.85.05.25.35.55.55.65.76.36.46.76.36.46.86.96.96.86.86.97.06.9
Profit before tax23.217.017.118.610.914.011.818.313.3-6.5-6.1-4.4-11.93.018.613.710.69.07.63.11.20.7-2.7-0.83.67.5-4.17.33.714.418.425.813.123.217.420.616.918.318.114.713.115.017.815.917.723.736.112.65.4-3.535.145.344.430.649.531.336.6-0.127.88.916.513.419.17.622.14.7
Tax7.95.66.16.43.64.86.26.52.33.12.70.4-2.31.04.40.73.32.32.51.00.81.00.40.30.31.60.61.91.4-2.44.510.46.813.26.17.25.97.56.75.24.26.36.55.76.210.612.7-19.71.4-0.59.011.411.38.612.67.99.4-0.37.12.44.43.55.02.96.71.7
Net profit15.311.410.912.27.39.25.611.811.0-9.6-8.8-4.8-9.62.114.212.97.36.75.12.10.4-0.3-3.0-1.13.26.0-4.75.42.316.813.915.46.210.011.413.511.010.711.49.58.98.711.310.211.513.123.332.34.0-3.026.133.833.122.136.823.327.20.220.76.612.29.914.14.715.43.0
EPS ₹21.7816.3015.6117.4010.3713.078.0216.8815.66-13.72-12.63-6.81-13.632.9520.3318.4710.479.587.342.960.61-0.47-4.36-1.594.618.51-6.667.763.2824.0019.8822.038.9214.2216.2419.2115.7315.3416.266.796.396.218.107.278.189.3316.6623.072.82-2.1118.6524.1623.6215.7626.3016.6619.420.1414.764.698.687.0610.103.3810.982.15
Revenue YoY————-32.4%9.2%-4.5%47.0%108.9%11.0%34.3%-8.1%-13.9%41.1%52.5%69.5%74.7%37.3%2.8%8.6%-0.1%—-27.3%-24.9%-12.6%-20.3%-21.3%9.0%1.1%66.4%101.1%39.7%23.1%-4.4%-16.9%9.2%21.1%23.4%21.5%-18.7%-12.1%-6.0%0.9%19.4%29.2%-5.9%12.6%-17.4%-33.1%-19.7%-23.9%47.5%79.8%72.7%61.8%-3.6%-8.4%-12.9%-13.5%-5.5%10.8%5.2%-1.0%-7.3%2.7%13.9%
Profit YoY————-52.4%-19.8%-48.6%-3.0%50.9%-204.9%-257.3%-140.4%-187.1%————224.2%-60.2%-71.6%-93.6%—-159.3%-153.4%651.2%———-28.8%182.0%—184.2%171.7%-40.7%-18.2%-12.8%76.3%7.8%0.1%-29.3%-18.8%-19.0%-0.4%7.0%28.0%50.2%105.6%217.4%-65.5%-122.6%12.0%4.7%737.7%—41.0%-31.0%-17.8%-99.1%-43.9%-71.9%-55.3%4845.0%-31.6%-28.0%26.5%-69.6%

Returns & margins

trailing-twelve-month, per quarter
MAR '25JUN '25SEP '25DEC '25MAR '26JUN '26
ROE1.0%2.8%4.4%4.3%3.8%0.8%
ROCE1.6%2.8%3.8%3.8%4.1%2.9%
Net margin1.4%4.0%6.3%5.9%4.5%0.8%
EBITDA margin6.7%10.3%13.3%13.4%12.1%9.3%
Debt / equity0.990.991.021.021.001.00
Interest coverage1.843.044.433.832.261.11
Asset turnover0.320.310.310.320.370.41

Balance sheet

equity vs borrowings over time · ₹ crore
SEP '24MAR '25SEP '25MAR '26
Share capital7.07.07.07.0
Other equity / reserves706.5715.4739.0743.7
Total equity713.5722.4746.0750.7
Borrowings610.4714.0760.2752.7
Current liabilities311.2296.6331.7337.2
Non-current liabilities506.8606.4622.7623.0
Total assets1,531.61,625.41,700.51,710.9
Property, plant & equipment392.0381.3368.51,331.2
Capital work-in-progress678.6805.4895.52.6
Investments0.20.20.10.1
Inventories99.3100.692.8103.5
Receivables65.757.765.248.3
Cash & equivalents164.8143.0126.790.2

Cash flow

annual · ₹ crore · line = free cash flow
FY25FY26
Cash from operations-37.675.6
Cash from investing-227.3-137.0
Cash from financing177.88.6
Capex243.1171.6
Free cash flow-280.8-96.1
Dividends paid4.20.8

Where the assets sit

Mar '26 · ₹ crore
Fixed assets (PPE)
₹1,331.2 cr78%
CWIP
₹2.6 cr0%
Investments
₹0.1 cr0%
Inventories
₹103.5 cr6%
Receivables
₹48.3 cr3%
Cash & equivalents
₹90.2 cr5%
Other assets
₹135.1 cr8%

Peer comparison

largest in Unclassified · this company in bold
CompanyMarket cap ₹crPriceP/EP/BROE
Avantel Limited36,86,04,549138.69—1059360.680.0%
Ducol Organics And Colours Limited19,55,275120.00—20089.130.0%
Jio Platforms Limited12,57,1811,406.40—3.57—
SBI Funds Management Limited1,01,750499.55———
Tamilnadu Telecommunication Limited91,3149.93———
Manipal Health Enterprises Limited76,294646.70———
INDO-MIM Limited59,0421,219.50———
AvenuesAI Limited45,138129.25153.69.516.2%
Dhoot Transmission Limited32,7611,601.60—8.11—
3M India Limited31,07127,570.0053.817.5732.7%
Deccan Cements Limited671479.20114.90.890.8%

StoxGud checklist: Bearish setup · 1/10

  • Price above 50-day average
  • Price above 200-day average
  • 50-day average above 200-day (uptrend)
  • RSI in healthy 40–70 zone
  • Positive 1-year return
  • Return on equity above 15%
  • Debt to equity below 1
  • Revenue growing year on year
  • Net profit margin above 10%
  • P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-12.1%
6 months-26.5%
1 year-53.6%
3Y CAGR-3.9%
5Y CAGR-8.3%
10Y CAGR-1.3%
50-day avg₹537.63
200-day avg₹599.97
RSI (14)17

FAQs

What is the share price of Deccan Cements Limited?

Deccan Cements Limited (DECCANCE) closed at ₹479.20 on NSE on 06 Nov 2026.

What is the market cap of Deccan Cements Limited?

₹671 crore at the latest close.

What is the P/E ratio of Deccan Cements Limited?

114.9, on trailing-twelve-month earnings from its filings.

How fast is Deccan Cements Limited growing?

Deccan Cements Limited: Latest-quarter revenue is up 45.7% year on year, profit down 148.1%.

How profitable is Deccan Cements Limited?

On a trailing-twelve-month basis return on equity is 0.8%, return on capital employed 2.9%, operating margin 9.3%, net margin 0.8%.

How much debt does Deccan Cements Limited have?

Deccan Cements Limited is moderately geared: debt to equity is 1.00 with borrowings of ₹753 cr against cash of ₹90 cr (balance sheet of 2026-03-31). Operating profit covers interest 1.1 times.

Financials parsed from Deccan Cements Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from JUN '24, annual from FY25, balance sheet from Sep '24. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.